Bronchiectasis not due to cystic fibrosis.

Autores de IIS La Fe

• 

  Miguel Ángel Martínez García

  Autor

Participantes ajenos a IIS La Fe

• Girón R
• Golpe R

Grupos

• Neumología

  

  Leader

  Miguel Ángel Martínez García

Abstract

Bronchiectasis is a clinical-radiological condition composed of irreversible bronchial dilation due to inflammation and infection of the airways, which causes respiratory symptoms, usually productive cough and infectious exacerbations. Bronchiectasis can have multiple causes, both pulmonary and extrapulmonary, and its clinical presentation is very heterogenous. Its prevalence is unknown, although up to 35-50% of severe COPD and 25% of severe asthma present them, so their underdiagnosis is evident. Chronic bacterial bronchial infection is common, and Pseudomonas aeruginosa is the pathogen that has been found to imply a worse prognosis. Treatment of bronchiectasis has three fundamental characteristics: it must be multidisciplinary (involvement of several specialties), pyramidal (from primary care to the most specialized units) and multidimensional (management of all aspects that make up the disease).

Copyright © 2024 Elsevier España, S.L.U. All rights reserved.

Keywords

• Antibióticos inhalados; Bronchial infection; Bronchiectasis; Bronquiectasias; Infección bronquial; Inhaled antibiotics; Macrolides; Macrólidos; Pseudomonas aeruginosa